A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study to assess the efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted Recombinant Protein Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of age and older. The major goals of this project are to assess the efficacy, safety, and immunogenicity of two CoV2 preS dTM-AS03 vaccines (monovalent and bivalent) in adults 18 years of age and older. Started in November 2021, 435 participants were enrolled from Kisumu and its surrounding counties Funded by SANOFI-Fred Hutchinson

The KEN SHE Study Outreach Awareness initiative aims to educate communities about the study’s objectives, promote understanding of its health benefits, and encourage active participation. Through interactive sessions, information materials, and open dialogues, the outreach team engages with women and girls to raise awareness about cervical cancer prevention, screening, and treatment. This approach not only fosters trust and transparency but also empowers participants with the knowledge they need to make informed health decisions, ultimately contributing to improved community well-bein